|
SLC25A24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.632980E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.174200E-01 |
| Normal-vs-Stage2 |
4.089600E-02 |
| Normal-vs-Stage3 |
1.738630E-01 |
| Normal-vs-Stage4 |
7.909700E-02 |
| Stage1-vs-Stage2 |
8.422100E-02 |
| Stage1-vs-Stage3 |
3.317400E-01 |
| Stage1-vs-Stage4 |
1.547440E-01 |
| Stage2-vs-Stage3 |
3.660800E-01 |
| Stage2-vs-Stage4 |
7.844800E-01 |
| Stage3-vs-Stage4 |
5.411800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.998360E-01 |
| Normal-vs-AfricanAmerican |
4.773200E-01 |
| Normal-vs-Asian |
5.293000E-01 |
| Caucasian-vs-AfricanAmerican |
1.925960E-01 |
| Caucasian-vs-Asian |
8.728200E-01 |
| AfricanAmerican-vs-Asian |
3.327200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.251500E-02 |
| Normal-vs-Female |
2.985600E-01 |
| Male-vs-Female |
2.373600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.242800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.732500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.192100E-02 |
| Normal-vs-Age(81-100Yrs) |
3.381600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.367550E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.303600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.574200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.270000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.959600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.063800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.139400E-01 |
| Classical-VS-Follicular |
6.382100E-04 |
| Classical-VS-Other |
5.010000E-01 |
| Classical-VS-Normal |
7.562600E-01 |
| Tall-VS-Follicular |
1.497950E-02 |
| Tall-VS-Other |
3.933400E-01 |
| Tall-VS-Normal |
7.759200E-01 |
| Follicular-VS-Other |
6.452000E-01 |
| Follicular-VS-Normal |
2.495000E-03 |
| Other-VS-Normal |
3.366000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.275510E-02 |
| Normal-vs-N1 |
1.815620E-01 |
| N0-vs-N1 |
7.363200E-01 |
|
|
